These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 29920587)
1. GC-MS and GC-IR Analyses of the Methoxy-1-n-pentyl-3-(1-naphthoyl)-indoles: Regioisomeric Designer Cannabinoids. Thaxton-Weissenfluh A; Belal TS; DeRuiter J; Smith F; Abiedalla Y; Neel L; Abdel-Hay KM; Clark CR J Chromatogr Sci; 2018 Oct; 56(9):779-788. PubMed ID: 29920587 [TBL] [Abstract][Full Text] [Related]
2. GC-MS studies on the six naphthoyl-substituted 1-n-pentyl-indoles: JWH-018 and five regioisomeric equivalents. Thaxton A; Belal TS; Smith F; DeRuiter J; Abdel-Hay KM; Clark CR Forensic Sci Int; 2015 Jul; 252():107-13. PubMed ID: 25965306 [TBL] [Abstract][Full Text] [Related]
3. Analytical studies on the 2-naphthoyl substituted-1-n-pentylindoles: Regioisomeric synthetic cannabinoids. Thaxton-Weissenfluh A; Alsegiani AS; Abiedalla Y; DeRuiter J; Smith F; Clark CR J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Mar; 1077-1078():77-84. PubMed ID: 29413581 [TBL] [Abstract][Full Text] [Related]
4. Gas Chromatography-Mass Spectrometry (GC-MS) and Gas Chromatography-Infrared (GC-IR) Analyses of the Chloro-1- n-pentyl-3-(1-naphthoyl)-Indoles: Regioisomeric Cannabinoids. Abdel-Hay KM; Belal TS; Abiedalla Y; Thaxton-Weissenfluh A; DeRuiter J; Smith F; Clark CR Appl Spectrosc; 2019 Apr; 73(4):433-443. PubMed ID: 30347999 [TBL] [Abstract][Full Text] [Related]
5. Mass spectral studies on 1-n-pentyl-3-(1-naphthoyl)indole (JWH-018), three deuterium-labeled analogues and the inverse isomer 1-naphthoyl-3-n-pentylindole. Thaxton A; Belal TS; Smith F; DeRuiter J; Abdel-Hay KM; Clark CR Rapid Commun Mass Spectrom; 2015 May; 29(9):871-7. PubMed ID: 26377015 [TBL] [Abstract][Full Text] [Related]
6. GC-MS and FTIR evaluation of the six benzoyl-substituted-1-pentylindoles: isomeric synthetic cannabinoids. Smith FT; DeRuiter J; Abdel-Hay K; Clark CR Talanta; 2014 Nov; 129():171-82. PubMed ID: 25127581 [TBL] [Abstract][Full Text] [Related]
7. Correlation of vapor phase infrared spectra and regioisomeric structure in synthetic cannabinoids. Smith LW; Thaxton-Weissenfluh A; Abiedalla Y; DeRuiter J; Smith F; Clark CR Spectrochim Acta A Mol Biomol Spectrosc; 2018 May; 196():375-384. PubMed ID: 29486418 [TBL] [Abstract][Full Text] [Related]
8. GC-MS differentiation of the six regioisomeric dimethoxybenzoyl-1-pentylindoles: Isomeric cannabinoid substances. Abdel-Hay KM; De Ruiter J; Smith F; Alsegiani AS; Thaxton-Weissenfluh A; Clark CR J Pharm Biomed Anal; 2016 Jun; 125():360-8. PubMed ID: 27107854 [TBL] [Abstract][Full Text] [Related]
9. Positional isomer differentiation of synthetic cannabinoid JWH-081 by GC-MS/MS. Kusano M; Zaitsu K; Nakayama H; Nakajima J; Hisatsune K; Moriyasu T; Matsuta S; Katagi M; Tsuchihashi H; Ishii A J Mass Spectrom; 2015 Mar; 50(3):586-91. PubMed ID: 25800195 [TBL] [Abstract][Full Text] [Related]
10. GC-MS analysis of the regioisomeric methoxy- and methyl-benzoyl-1-pentylindoles: Isomeric synthetic cannabinoids. Abdel-Hay KM; DeRuiter J; Smith F; Belal TS; Clark CR Sci Justice; 2015 Sep; 55(5):291-8. PubMed ID: 26385710 [TBL] [Abstract][Full Text] [Related]
11. Development of a mass spectrometric hydroxyl-position determination method for the hydroxyindole metabolites of JWH-018 by GC-MS/MS. Kusano M; Zaitsu K; Yamanaka M; Hisatsune K; Asano T; Taki K; Hayashi Y; Tsuchihashi H; Ishii A J Mass Spectrom; 2016 May; 51(5):350-7. PubMed ID: 27194519 [TBL] [Abstract][Full Text] [Related]
12. Differentiation of methoxybenzoylpiperazines (OMeBzPs) and methylenedioxybenzylpiperazines (MDBPs) By GC-IRD and GC-MS. Abdel-Hay KM; DeRuiter J; Clark CR Drug Test Anal; 2012 Jun; 4(6):430-40. PubMed ID: 22170873 [TBL] [Abstract][Full Text] [Related]
13. Analytical differentiation of 1-alkyl-3-acylindoles and 1-acyl-3-alkylindoles: isomeric synthetic cannabinoids. DeRuiter J; Smith FT; Abdel-Hay K; Clark CR Anal Chem; 2014 Apr; 86(8):3801-8. PubMed ID: 24611491 [TBL] [Abstract][Full Text] [Related]
14. CBL-2201. Report on a new designer drug: Napht-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate. Kondrasenko AA; Goncharov EV; Dugaev KP; Rubaylo AI Forensic Sci Int; 2015 Dec; 257():209-213. PubMed ID: 26386336 [TBL] [Abstract][Full Text] [Related]
15. Quadrupole-time-of-flight mass spectrometry screening for synthetic cannabinoids in herbal blends. Ibáñez M; Bijlsma L; van Nuijs AL; Sancho JV; Haro G; Covaci A; Hernández F J Mass Spectrom; 2013 Jun; 48(6):685-94. PubMed ID: 23722959 [TBL] [Abstract][Full Text] [Related]
16. Prediction of designer drugs: synthesis and spectroscopic analysis of synthetic cannabinoid analogues of 1H-indol-3-yl(2,2,3,3-tetramethylcyclopropyl)methanone and 1H-indol-3-yl(adamantan-1-yl)methanone. Carlsson A; Lindberg S; Wu X; Dunne S; Josefsson M; Åstot C; Dahlén J Drug Test Anal; 2016 Oct; 8(10):1015-1029. PubMed ID: 26526273 [TBL] [Abstract][Full Text] [Related]
17. Characterization of in vitro metabolites of JWH-018, JWH-073 and their 4-methyl derivatives, markers of the abuse of these synthetic cannabinoids. Gambaro V; Arnoldi S; Bellucci S; Casagni E; Dell'Acqua L; Fumagalli L; Pallavicini M; Roda G; Rusconi C; Valoti E J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Apr; 957():68-76. PubMed ID: 24657413 [TBL] [Abstract][Full Text] [Related]
18. Identification and quantification of synthetic cannabinoids in 'spice-like' herbal mixtures: a snapshot of the German situation in the autumn of 2012. Langer N; Lindigkeit R; Schiebel HM; Ernst L; Beuerle T Drug Test Anal; 2014; 6(1-2):59-71. PubMed ID: 23723183 [TBL] [Abstract][Full Text] [Related]
19. Isomeric fluoro-methoxy-phenylalkylamines: a new series of controlled-substance analogues (designer drugs). Rösner P; Quednow B; Girreser U; Junge T Forensic Sci Int; 2005 Mar; 148(2-3):143-56. PubMed ID: 15639609 [TBL] [Abstract][Full Text] [Related]